Finding new uses for existing drugs to treat Alzheimer's disease
Computational drug repurposing for Alzheimer's disease
This study is looking at how we can use some already approved medications in new ways to help treat Alzheimer's disease, which impacts memory and thinking for many adults, by checking genetic information to find the best options that could make a difference.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10954714 on NIH RePORTER |
What this research studies
This research investigates how existing medications can be repurposed to treat Alzheimer's disease, a condition that severely affects memory and cognition in millions of adults. The approach involves analyzing genetic data to identify drugs that can reverse harmful gene changes associated with Alzheimer's. By using advanced informatics and electronic health records, the researchers aim to validate these drug candidates in real-world clinical settings. This method promises to be faster and more cost-effective than traditional drug development.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer's disease.
Not a fit: Patients with early-stage cognitive impairment or those without a confirmed diagnosis of Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for Alzheimer's disease, improving the quality of life for patients.
How similar studies have performed: Previous research has shown promise in drug repurposing for other conditions, indicating potential success for this novel approach in Alzheimer's treatment.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Grabowska, Monika Eliana — Vanderbilt University
- Study coordinator: Grabowska, Monika Eliana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.